Salvatore Crisafulli
- Toxicology top 1%
- Pharmacovigilance and Adverse Drug Reactions 5
- Geriatrics and Gerontology top 5%
- Pharmaceutical Practices and Patient Outcomes 4
- Family Practice top 10%
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies 5
-
- Health Systems, Economic Evaluations, Quality of Life 6
- Pharmaceutical Economics and Policy 5
-
- Pituitary Gland Disorders and Treatments 4
- Growth Hormone and Insulin-like Growth Factors 4
-
- Pharmaceutical studies and practices 3
- Co-authors
- Gianluca TrifiròJanet SultanaPaola Maria CutroneoYlenia IngrasciottaGaetano CaramoriSaad ShakirEdoardo SpinaNicoletta Luxi
- Journals
- SHILAP Revista de lepidopterología (5 papers)Annals of Internal Medicine (1 paper)Scientific Reports (2 papers)
- Partner nations
- ItalyUnited KingdomMalta
In The Last Decade
Salvatore Crisafulli
35 papers receiving 852 citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Toxicology 153
- Geriatrics and Gerontology 101
- Applied Microbiology and Biotechnology 39
- Family Practice 25
- Infectious Diseases 183
Countries citing papers authored by Salvatore Crisafulli
This map shows the geographic impact of Salvatore Crisafulli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salvatore Crisafulli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salvatore Crisafulli more than expected).
Fields of papers citing papers by Salvatore Crisafulli
This network shows the impact of papers produced by Salvatore Crisafulli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salvatore Crisafulli. The network helps show where Salvatore Crisafulli may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Salvatore Crisafulli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | Conducting and interpreting disproportionality analyses derived from spontaneous reporting systemsbreakdown → | 2024 | 66 |
| 7 | 2024 | 17 | |
| 8 | 2024 | 4 | |
| 9 | 2023 | 10 | |
| 10 | 2023 | 9 | |
| 11 | 2023 | 9 | |
| 12 | 2022 | 2 | |
| 13 | 2022 | 20 | |
| 14 | 2021 | 53 | |
| 15 | 2021 | 5 | |
| 16 | 2021 | 10 | |
| 17 | 2021 | 12 | |
| 18 | 2021 | 15 | |
| 19 | 2020 | 102 | |
| 20 | 2018 | 136 |
About Salvatore Crisafulli
Salvatore Crisafulli is a scholar working on Toxicology, Family Practice and Geriatrics and Gerontology, having authored 38 papers that have together received 872 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (6 papers), COVID-19 Clinical Research Studies (5 papers), Pharmaceutical Economics and Policy (5 papers), Pharmacovigilance and Adverse Drug Reactions (5 papers), Pituitary Gland Disorders and Treatments (4 papers), Growth Hormone and Insulin-like Growth Factors (4 papers), Pharmaceutical Practices and Patient Outcomes (4 papers) and Pharmaceutical studies and practices (3 papers). The work is most often cited by research in Toxicology (153 citations), Geriatrics and Gerontology (101 citations) and Applied Microbiology and Biotechnology (39 citations). Salvatore Crisafulli has collaborated with scholars based in Italy, United Kingdom and Malta. Frequent co-authors include Gianluca Trifirò, Janet Sultana, Paola Maria Cutroneo, Ylenia Ingrasciotta, Gaetano Caramori, Saad Shakir, Edoardo Spina, Nicoletta Luxi, Francesco Salvo and Valentina Isgrò. Their work appears in journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.